Long Circulating Liposomes: Old Drugs, New Therapeutics
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer Berlin Heidelberg

9783662221174, 9783662221150

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Long Circulating Liposome-Encapsulated Tumor Necrosis Factor in the Treatment of Solid Tumors

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_4 ◽

1998 ◽

pp. 51-60

Author(s):

Timo L. M. ten Hagen ◽

Alexander H. van der Veen ◽

Alexander M. M. Eggermont

Keyword(s):

Tumor Necrosis Factor ◽

Solid Tumors ◽

Tumor Necrosis ◽

Necrosis Factor

Download Full-text

Long Circulating Liposomes for Diagnostic Imaging

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_17 ◽

1998 ◽

pp. 241-255

Author(s):

Vladimir S. Trubetskoy ◽

Vladimir P. Torchilin

Keyword(s):

Diagnostic Imaging

Download Full-text

Clinical and Preclinical Studies with Low-Clearance Liposomal Amikacin (MiKasome®)

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_15 ◽

1998 ◽

pp. 213-225 ◽

Cited By ~ 8

Author(s):

Robert M. Fielding ◽

Geoffrey Mukwaya ◽

Robert A. Sandhaus

Keyword(s):

Preclinical Studies

Download Full-text

Enhancement of Doxorubicin by Encapsulation in Long Circulating Thermosensitive Liposomes Combined with Local Hyperthermia

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_7 ◽

1998 ◽

pp. 97-109 ◽

Cited By ~ 1

Author(s):

Kazuo Maruyama

Keyword(s):

Local Hyperthermia ◽

Thermosensitive Liposomes

Download Full-text

Initial Clinical Evaluation of Pegylated-Liposomal Doxorubicin in Solid Tumors

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_11 ◽

1998 ◽

pp. 165-174 ◽

Cited By ~ 11

Author(s):

Alberto A. Gabizon ◽

Franco M. Muggia

Keyword(s):

Solid Tumors ◽

Clinical Evaluation ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Initial Clinical Evaluation

Download Full-text

AmBisome®: Long Circulating Liposomal Formulation of Amphotericin B

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_13 ◽

1998 ◽

pp. 185-206 ◽

Cited By ~ 7

Author(s):

Jill P. Adler-Moore ◽

Richard T. Proffitt

Keyword(s):

Amphotericin B ◽

Liposomal Formulation

Download Full-text

Antibacterial Therapy with Sterically Stabilized Liposome Formulations

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_12 ◽

1998 ◽

pp. 177-183

Author(s):

Irma A. J. M. Bakker-Woudenberg ◽

Gerrit Storm ◽

Martin C. Woodle

Keyword(s):

Antibacterial Therapy

Download Full-text

DaunoXome® (Liposomal Daunorubicin) for First-Line Treatment of Advanced, HIV-Related Kaposi’s Sarcoma

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_10 ◽

1998 ◽

pp. 147-163 ◽

Cited By ~ 1

Author(s):

Geoffrey Mukwaya ◽

Eric A. Forssen ◽

Paul Schmidt ◽

Michael Ross

Keyword(s):

Kaposi's Sarcoma ◽

Kaposi’S Sarcoma ◽

Line Treatment ◽

First Line ◽

Liposomal Daunorubicin ◽

First Line Treatment

Download Full-text

Therapy of Human Carcinoma Xenografts with Doxorubicin Encapsulated in Sterically Stabilized Liposomes (DOXIL®): Efficacy and Safety Studies

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_5 ◽

1998 ◽

pp. 61-72 ◽

Cited By ~ 2

Author(s):

Jan Vaage ◽

Paul S. Uster ◽

Peter K. Working

Keyword(s):

Efficacy And Safety ◽

Human Carcinoma ◽

Sterically Stabilized Liposomes ◽

Safety Studies

Download Full-text

Small Molecule Ligands for Targeting Long Circulating Liposomes

Long Circulating Liposomes: Old Drugs, New Therapeutics ◽

10.1007/978-3-662-22115-0_20 ◽

1998 ◽

pp. 287-295

Author(s):

Martin C. Woodle ◽

Danilo D. Lasic ◽

Gerrit Storm

Keyword(s):

Small Molecule ◽

Small Molecule Ligands

Download Full-text

Long Circulating Liposomes: Old Drugs, New TherapeuticsLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer Berlin Heidelberg

Long Circulating Liposome-Encapsulated Tumor Necrosis Factor in the Treatment of Solid Tumors

Long Circulating Liposomes for Diagnostic Imaging

Clinical and Preclinical Studies with Low-Clearance Liposomal Amikacin (MiKasome®)

Enhancement of Doxorubicin by Encapsulation in Long Circulating Thermosensitive Liposomes Combined with Local Hyperthermia

Initial Clinical Evaluation of Pegylated-Liposomal Doxorubicin in Solid Tumors

AmBisome®: Long Circulating Liposomal Formulation of Amphotericin B

Antibacterial Therapy with Sterically Stabilized Liposome Formulations

DaunoXome® (Liposomal Daunorubicin) for First-Line Treatment of Advanced, HIV-Related Kaposi’s Sarcoma

Therapy of Human Carcinoma Xenografts with Doxorubicin Encapsulated in Sterically Stabilized Liposomes (DOXIL®): Efficacy and Safety Studies

Small Molecule Ligands for Targeting Long Circulating Liposomes

Long Circulating Liposomes: Old Drugs, New Therapeutics
Latest Publications